Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma

被引:92
|
作者
Summanen, P [1 ]
Immonen, I [1 ]
Kivela, T [1 ]
Tommila, P [1 ]
Heikkonen, J [1 ]
Tarkkanen, A [1 ]
机构
[1] HELSINKI UNIV,CENT HOSP,DEPT ONCOL,FIN-00290 HELSINKI,FINLAND
关键词
D O I
10.1136/bjo.80.8.732
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims/background - To analyse radiation related complications and secondary enucleation after irradiation of malignant uveal melanoma with ruthenium-106 plaques. Methods - A series of 100 consecutive eyes irradiated in 1981-91 was analysed using the life table method and the Cox proportional hazards model. The median apical and scleral tumour dose was 100 Gy (range 15-200 Gy) and 1000 Gy (range 200-1200 Gy), respectively, The median follow up time was 2.8 and 2.0 years (range 1 month to 10 years) for anterior and posterior segment complications, respectively, Results - The 3 and 5 year probabilities of being without radiation cataract were 73% and 63%, without neovascular glaucoma 91% and 81%, without vitreous haemorrhage 83% and 74%, without radiation maculopathy 85% and 70%, and without radiation optic neuropathy 90% and 88%, respectively. The risk of radiation cataract was highest with large tumour size (T1+T2 v T3, p=0.0027; height less than or equal to 5 v >5 mm, P=0.029; largest basal diameter (LED) less than or equal to 15 v >15 mm, p<0,0001) and location of anterior tumour margin anterior v posterior to the equator (p=0,0003); the risk of neovascular glaucoma with large size (T1+T2 v T3, p=0,039; LBD less than or equal to 15 mm v 15 mm, p=0,021); and the risk of maculopathy and optic neuropathy with proximity of the posterior tumour margin to the fovea and the optic disc (less than or equal to 1.5 v >1.5 mm; p=0,030 and p=0,0004, respectively), In Cox's multivariate analysis the strongest risk indicator for radiation cataract (RR 1.5, 95% CI 1.4-1.6) and vitreous haemorrhage (RR 1.6, 95% CI 1,4-1.8) was the height of the armour; for neovascular glaucoma the TNM class (RR 6.2, 95% CI 2.7-13.8); for radiation maculopathy location of posterior tumour margin within 2 mm from the fovea (RR 3.4, 95% CI 2.0-6.0); and for radiation optic neuropathy location of tumour margin within 1 DD of the optic disc (RR 6.1, 95% CI 3.0-12,4). The 3 and 5 year probabilities of avoiding enucleation were 92% and 85%, respectively, Ten eyes were enucleated - six because of recurrent tumour growth, three because of treatment: complications, and one because of mistakenly suspected extraocular growth. Conclusion - The results suggest that the frequency of radiation related complications after ruthenium brachytherapy of uveal melanoma is acceptable, in particular as regard irradiation of small and medium sized tumours for which ruthenium therapy generally is recommended.
引用
收藏
页码:732 / 739
页数:8
相关论文
共 50 条
  • [1] Proliferative Radiation Retinopathy after Plaque Radiotherapy for Uveal Melanoma
    Bianciotto, Carlos
    Shields, Carol L.
    Pirondini, Cesare
    Mashayekhi, Arman
    Furuta, Minoru
    Shields, Jerry A.
    OPHTHALMOLOGY, 2010, 117 (05) : 1005 - 1012
  • [2] Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma
    Seregard, S
    Lundell, G
    Lax, I
    Trampe, EA
    Kock, E
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 1997, 75 (02): : 148 - 154
  • [3] PLAQUE RADIOTHERAPY FOR UVEAL MELANOMA
    SHIELDS, JA
    SHIELDS, CL
    DEPOTTER, P
    CUUNJIENG, A
    HERNANDEZ, C
    BRADY, LW
    INTERNATIONAL OPHTHALMOLOGY CLINICS, 1993, 33 (03) : 129 - 135
  • [4] VITREOUS HEMORRHAGE AFTER PLAQUE RADIOTHERAPY FOR UVEAL MELANOMA
    Bianciotto, Carlos
    Shields, Carol L.
    Pirondini, Cesare
    Mashayekhi, Arman
    Furuta, Minoru
    Shields, Jerry A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (06): : 1156 - 1164
  • [5] Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma
    Mashayekhi, Arman
    Tuncer, Samuray
    Shields, Carol L.
    Shields, Jerry A.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (03) : 399 - 409
  • [6] Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma
    Gündüz, K
    Shields, CL
    Shields, JA
    Cater, J
    Freire, JE
    Brady, LW
    ARCHIVES OF OPHTHALMOLOGY, 1999, 117 (05) : 609 - 614
  • [7] RUTHENIUM PLAQUE BRACHYTHERAPY FOR UVEAL MELANOMA
    Smaniotto, D.
    Diletto, B.
    Fersino, S.
    Azario, L.
    Sammarco, M. G.
    Pagliara, M.
    Caputo, M. C.
    Scupola, A.
    D' Amico, G.
    Tagliaferri, L.
    Luzi, S.
    Balestrazzi, E.
    Blasi, M. A.
    Cellini, N.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S116 - S116
  • [8] Ruthenium plaque radiotherapy for posterior uveal melanoma. The Swedish experience.
    Seregard, S
    Trampe, E
    Lax, I
    Kock, E
    Lundell, G
    VISION RESEARCH, 1996, 36 : 3144 - 3144
  • [9] Adjunctive plaque radiotherapy after local resection of uveal melanoma
    Damato, B
    RADIOTHERAPY OF OCULAR DISEASE, 1997, 30 : 123 - 132
  • [10] EPISCLERAL PLAQUE RADIOTHERAPY FOR UVEAL MELANOMA
    GIBLIN, ME
    SHIELDS, JA
    AUGSBURGER, JJ
    BRADY, LW
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1989, 17 (02): : 153 - 156